Learn what we and our supporters have been getting up to.
Exciting outcomes from Cure Parkinson's NZ-funded research.
Read MoreCEO Daniel attends international meetings with partner organisations.
Read MoreA phase 2 study of the GLP-1R agonist lixisenatide in people with early-stage Parkinson's, conducted in France, is reported in the New England Journal of Medicine.
Read MoreNZ news media interviewed our CEO on World Parkinson's Day as we launched our documentary One in 37 and discussed global collaborations as we work toward a cure.
Read MorePrestigious British medical journals provide a state of play on Parkinson's research and ask "what next"?
Read MoreThe US Federal Government may soon be joining the team as the urgent need for research leading to prevention and a cure gains support in high places.
Read MoreA 62-year-old man with late-stage Parkinson's and severe gait impairments regains the ability to walk normally following experimental treatment in Switzerland.
Read MoreWhile most of the country was watching the RWC final live, our small team of CPNZ athletes blitzed the Auckland Harbour Bridge in blustery conditions at the 2023 Auckland Marathon.
Read MoreCould wearable devices one day be used to predict who might go on to receive a Parkinson's diagnosis? Quite possibly. Machine learning models fed movement data recently did just that.
Read MoreDistinguished Professor Sir Richard Faull, Trustee of Cure Parkinson's NZ, likens our NZ brain researchers to the All Blacks.
Read MoreTrustee Marise Winthrop shares her thoughts on the importance of our work toward a cure for Parkinson's.
Read MoreSupporter David Kidd, a UK-based kiwi living with Parkinson's, shared this poignant, beautiful and brilliantly optimistic video with us for screening at our recent fundraising dinner.
Read MoreOur CEO Daniel McGowan recently spent an hour in the studio with host Tim Beveridge on his 1ZB radio show "The Weekend Collective".
Read MoreOur CEO Daniel McGowan recently travelled to the UK and Europe bringing back the latest research updates and forming some strong connections.
Read MoreNew biomarker enables accurate biochemical diagnosis of very early-stage Parkinson’s disease, ushering in a new era of clinical trials for Parkinson’s better geared for success.
Read MoreCould a cough medication really stop or slow Parkinson's progression? A trial getting underway this year will provide the answer.
Read MoreRob Spear and Sam Paterson really dug deep to raise funds for Cure Parkinson's NZ in February as they completed the two-day tandem Coast to Coast Challenge raising >$26,000.
Read MoreOn February 10 our CEO Daniel visited the NZ Brain Research Institute and BrainTree Wellness Centre in Christchurch.
Read MoreWe are very grateful to the Greenlea family and their Greenlea Foundation Trust for the generous donation of $100,000 for Parkinson's research in December 2022.
Read MoreWhen we talk about finding a cure for Parkinson's, what does that mean? Will there be a "silver bullet" treatment? Probably not, but there is good cause for hope.
Read MoreCure Parkinson's in the UK are at the core of global efforts to fight this awful disease, and we were thrilled to establish a partnership with them in October 2022.
Read MoreYou can download our latest quarterly newsletter here to stay up to date with planned events, research progress, fundraising opportunities and all our other news. The link below is to our Autumn 2024 newsletter.
Please remember to sign up for our monthly e-newsletter updates, and get in touch with us if you would like to receive a hard copy newsletter every quarter.
Download Newsletter